Management maintained guidance for the circular economy platform to contribute $50 million to $75 million to EBITDA in 2025, largely back-half loaded as utilization ramps up and sales increase. Costa ...
Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with best-in-class performance SAN DIEGO, Dec. 1, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback